Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elise, Reardon"'
Autor:
Nhut Le, Alonsa Heredia, Elise Reardon, E. Klingebiel, Charles B. Davis, Anthony Amoroso, Robert C. Gallo, Robert R. Redfield, J. K. Dominique
Publikováno v:
Proceedings of the National Academy of Sciences. 100:10411-10416
Propagation of R5 strains of HIV-1 on CD4 lymphocytes and macrophages requires expression of the CCR5 coreceptor on the cell surface. Individuals lacking CCR5 (CCR5Δ32 homozygous genotype) are phenotypically normal and resistant to infection with HI
Autor:
Andrew L. Lobashevsky, Alonso Heredia, Mary C Schneider, Mark H. Deierhoi, Eugene Schweitzer, Diane R. Post, Charles E. L. B. Davis, Adriana Zeevi, Carol Bentlejewski, Judith A. Britz, Richard Kowalski, Robert R. Redfield, John J. Fung, Elise Reardon, Ron Shapiro, Judy M Thomas
Publikováno v:
Clinical Transplantation. 17:77-88
Each year, 55 000 organ transplants are performed worldwide. Cumulatively, the number of living organ recipients is now estimated to be over 300 000. Most of these transplant recipients will remain on immunosuppressive drugs for the remainder of thei
Autor:
Davide Zella, Nhut Le, Robert R. Redfield, Elise Reardon, Alonso Heredia, Erin Klingebiel, Anthony Amoroso, Charles B. Davis, Joyelle K. Dominique
Publikováno v:
Proceedings of the National Academy of Sciences. 100:4179-4184
The β-chemokines RANTES (regulated on activation, normal T cell expressed and secreted), macrophage inflammatory protein-1α (MIP-1α), and MIP-1β are the natural ligands of the HIV-1 coreceptor CCR5 and compete with the virus for receptor binding.
Autor:
Richard, Kowalski, Diane, Post, Mary C, Schneider, Judith, Britz, Judy, Thomas, Mark, Deierhoi, Andrew, Lobashevsky, Robert, Redfield, Eugene, Schweitzer, Alonso, Heredia, Elise, Reardon, Charles, Davis, Carol, Bentlejewski, John, Fung, Ron, Shapiro, Adriana, Zeevi
Publikováno v:
Clinical transplantation. 17(2)
Each year, 55 000 organ transplants are performed worldwide. Cumulatively, the number of living organ recipients is now estimated to be over 300 000. Most of these transplant recipients will remain on immunosuppressive drugs for the remainder of thei